Header graphic for print
FDA Life News and Trends Impacting the FDA and Life Science Industry

REMS and Other Drug Distribution Restrictions – Special NYSBA Program Will Be Held November 3 in NYC

Posted in Uncategorized

Risk185953030On November 3, 2016, the New York State Bar Association’s Sections, Food, Drug and Cosmetic Law and Antitrust Law, will put on a program in New York City: “REMS and Other Drug Distribution Restrictions: When Does a Brand Company Have a Duty to Deal with its Generic Rivals?”  The program will be held from 6:00-9:00 pm with a reception (cocktails and hors d’oeuvres) to follow.   The speakers below feature both federal and state antitrust lead attorneys working on these issues, as well as counsel for both reference and generic applicants, to provide for a lively and informative discussion and dialog.

Speakers:
Elinor R. Hoffmann, Office of the New York State Attorney General
Peter Safir, Covington & Burling LLP
Daniel W. Butrymowicz, Federal Trade Commission
Seth Silber, Wilson Sonsini Goodrich & Rosati 

Moderators:
William Reiss, Robins Kaplan LLP, Moderator
Janet B. Linn, Bleakley Platt & Schmidt, LLP, Moderator

Members: FREE
Non-Members: $25
*Please note that you must be a NYSBA member to join a section

Attendance is complimentary for anyone not requiring CLE credit.

REGISTER FOR THIS PROGRAM